Quantcast
Last updated on April 23, 2014 at 13:57 EDT

Latest Thrombolysis Stories

2012-12-12 05:01:12

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online Tuesday, December 11, in the journal Radiology. Oak Brook, Ill (PRWEB) December 11, 2012 Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology. “As many as 70 percent of ischemic stroke patients could have positive clinical outcomes with the additional use of intra-arterial...

2012-12-11 15:07:58

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology. "As many as 70 percent of ischemic stroke patients could have positive clinical outcomes with the additional use of intra-arterial revascularization using stents," said Martin Roubec, M.D., Ph.D., a neurologist in the Comprehensive Stroke Center at the University Hospital Ostrava in the Czech Republic. Ischemic stroke, the most common form...

2012-12-04 12:04:38

In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk. Stroke is when part...

2012-10-17 15:23:52

World Stroke Day & Swedish Medical Center Raise Awareness on New Treatments, Education DENVER, Oct. 17, 2012 /PRNewswire-USNewswire/ -- In just our mountainous corner of the world, nearly 433,000 Denver metro area residents will experience a stroke in their lifetime. The staggering statistics: one in six - or more than 850,000 Colorado residents will experience the same. In an effort to raise awareness of new treatments and prevention, Swedish Medical Center and The World Stroke...

2012-10-02 02:30:04

CAMBRIDGE, Mass., Oct. 2, 2012 /PRNewswire/ -- Thrombolytic Science International (TSI) today announced the initiation of a Phase 1 study of TS01, a new-generation clot-dissolving therapy intended for the treatment of acute ischemic stroke. This first-in-man randomized, double-blind, placebo-controlled study will assess the overall safety and tolerability of TS01 in healthy adults. TS01 selectively targets occlusive clots that cause strokes and spares hemostatic clots (good clots), resulting...

2012-09-18 06:29:44

Denver and Surrounding Region to Benefit from New Ischemic Stroke Treatment DENVER, Sept. 18, 2012 /PRNewswire-USNewswire/ -- Swedish Medical Center has become the first advanced care center in the state to bring an innovative medical device to its stroke care protocol, aimed at treating ischemic stroke patients faster and more efficiently than ever before. The device, known as the MAX System of Reperfusion Catheters and manufactured by Penumbra, Inc., is yet another tool for physicians...

2012-08-27 12:29:28

Every 40 seconds, someone in the United States has a stroke, usually caused when a clot blocks an artery that supplies blood to the brain. Now the results of two multicenter studies published online in The Lancet on August 26 are giving physicians new innovative tools proven to better remove these clots that block blood flow. The TREVO 2 clinical trial, (Thrombectomy Revascularization of Large Vessel Occlusions in Acute Ischemic Stroke) showed that the Trevo Retriever, a clot-removal...

New Device Proves Better Than Standard Tool At Removing Stroke-causing Blood Clots
2012-08-27 09:48:00

Stroke is the fourth leading cause of death and a common cause of long-term disability in the United States, but doctors have very few proven treatment methods. Now a new device that mechanically removes stroke-causing clots from the brain is being hailed as a game-changer. In a recent clinical trial, the SOLITAIRE Flow Restoration Device dramatically outperformed the standard mechanical treatment. Findings from the trial, called SOLITAIRE With the Intention for Thrombectomy (SWIFT), are...

2012-07-18 10:30:50

Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding suggests that a modified version of tPA could provide benefits to patients who have experienced a stroke, without increasing the risk of bleeding. The results will be published in the Journal of Neuroscience. "We may have been giving the right medication, for the wrong reason," says senior...

2012-06-27 10:35:00

The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI). This study helps allay previous concerns that tPA was too dangerous to use in patients on home anticoagulation and would lead to high risk for potentially fatal intracranial bleeding. "To date, we have no randomized trials or large cohort studies to guide us," says Ying Xian,...